1Jolles S.Areview of high-dose intravenous immunoglobulin(hdIVIg)in the treatment of the autoimmune blistering disorders.Clin Exp Dermatol.2001.26(2):127-131.
2Harman KE.Black MM.High-dose intravenous immune globulin for the treatment of autoimmune blistering diseases:an evaluation of its use in 14 cases.Br J Dermatol.1999.140(5):865-874.
3Misbah SA.Chapel HM.Adverse effects of intravenous immunoglobulin.Drug Saf.1993.9(4):254-262.
8Gtircan HM, Jeph S, Ahmed AR. Intravenous immunoglobulin therapy in autoimmune mucocutaneous blistering diseases : a review of the evidence for its efficacy and safety [ J ] . Am J Clin Dermatol, 2010, 11 (5): 315-326.
9赵辩.临床皮肤病学[M](第3版)[M].南京:江苏科学技术出版社,2001.613-618.
10Takamori K. Recent advances in the treatment of autoimmune bullous diseases[J]. J Dermatol, 2001,28( 11 ) :654 -657.
